Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
Add more filters











Database
Publication year range
1.
Zentralbl Chir ; 132(4): 358-64, 2007 Aug.
Article in German | MEDLINE | ID: mdl-17724641

ABSTRACT

BACKGROUND: Mesenchymal progenitor cells (MPCs or mesenchymal stem cells, MSC) have the capability for differentiation into various lineages of mesenchymal tissue. MPCs are widely distributed in a variety of tissues in the adult human body and also present in the fetal environment. However, MPCs are a rare population in these tissues. In this study we evaluated the possibility that MPCs or cells with MPC-like potency are present in the umbilical cord (UC). METHODS: Term UCs were collected and stored in sterile saline solution. The UCs (10 cm) were cut into 1 cm length, the vessels were striped manually and the tissue immersed in an enzyme cocktail for 3 h at 37 degrees C. The isolated umbilical cord mesenchymal progenitor cells (UCMPCs) were pelleted by low speed centrifugation, suspended and cultured. RESULTS: (1) Umbilical cord mesenchymal progenitor cells (UMPCs) could be isolated in sufficient quantities and (2) could be cultured easily. (3) These cells demonstrated a fibroblast-like phenotype. (4) They could be expanded in culture and induced to form several different types of cells. (5) In immunochemistry these cells express mesenchymal markers (CD 13, CD 105) but not haematopoetic lineage markers (CD 14 and CD 34). CONCLUSION: Our observation suggested that MPCs are present in human umbilical cord. Instead, it should be considered a valuable resource for the isolation of potent cells for cell-based therapies, especially in general and pediatric surgery.


Subject(s)
Mesenchymal Stem Cells/cytology , Umbilical Cord/cytology , Cell Culture Techniques , Cell Differentiation , Cell Lineage , Cell Separation , Cells, Cultured , Centrifugation , Fibroblasts/cytology , Humans , Immunochemistry , Phenotype
2.
Soc Work ; 38(4): 461-9, 1993 Jul.
Article in English | MEDLINE | ID: mdl-8362279

ABSTRACT

This study investigated the impact of three types of support--from family and friends, the workplace, and community services agencies--on the perceived stress and health outcomes of 133 employed caregivers of dependent parents. The stressor-support-stress-reaction model guided the research. Support from family and friends and community agencies was found to buffer the negative impact of caregiving and work and family role strain, and a supportive work environment was one predictor of lessened physical strain.


Subject(s)
Caregivers/psychology , Home Nursing/psychology , Social Support , Stress, Psychological/prevention & control , Activities of Daily Living , Aged , Community Health Services , Cross-Sectional Studies , Dependency, Psychological , Employment , Female , Health Status , Humans , Male , Middle Aged , Models, Psychological , New York City/epidemiology , Risk Factors , Role , Stress, Psychological/epidemiology , Stress, Psychological/psychology
3.
Thromb Res ; 50(5): 695-705, 1988 Jun 01.
Article in English | MEDLINE | ID: mdl-3261897

ABSTRACT

A 22 year-old woman with diabetes insipidus on chronic therapy with desmopressin acetate (DDAVP) developed recurrent venous thromboembolism and transient thrombocytopenia temporally related to the administration of DDAVP. Large increases in plasma von Willebrand factor (vWF), vWF-activity, and relative increases in the concentrations of the larger multimeric forms of vWF-antigen were observed, as well as a plasma factor which sensitized normal platelets to undergo spontaneous aggregation in vitro. Additional studies showed that the patient's plasma retained the platelet aggregation inducing activity after selective removal of vWF by immunoabsorption. The nature of the platelet activating factor and the relationship of this factor and the excessively increased and transiently abnormal vWF to the recurrent venous thromboembolism in this patient remain uncertain. Although the findings do not implicate definitively DDAVP in the elevation of vWF in this patient, it is suggested that its use be considered with caution in patients with diabetes mellitus and increased levels of vWF.


Subject(s)
Deamino Arginine Vasopressin/adverse effects , Diabetes Insipidus/drug therapy , Thrombocytopenia/chemically induced , Thromboembolism/chemically induced , Adult , Antithrombin III/metabolism , Deamino Arginine Vasopressin/therapeutic use , Female , Fibrinogen/metabolism , Humans , Platelet Aggregation , Staphylococcus aureus , von Willebrand Factor/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL